Advances in RA treatment require improved understanding of patient-specific therapy appropriateness, focusing on disease pathogenesis and heterogeneity. Current RA treatment algorithms lack biomarkers ...

Objective A panel of antibodies against three antigens, University Hasselt (UH)-rheumatoid arthritis (RA).305, 318 and 329, has been associated with lack of response to first-line therapy in the Care ...

Morning stiffness is common for people with arthritis and that got researchers to thinking that if they could time drug therapy to match the body’s rhythms when pain receptors are most active, they ...

Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — The 2022 American College of Rheumatology recommendations on integrative therapy in rheumatoid ...

First published in 2010, the EULAR recommendations for the management of RA, the most frequent inflammatory rheumatic disease, have been relied upon ...

Novel “RA Response Calculator” Uses AI and Real Patient Data to Help Doctors Better Tailor Treatment Plans At the European Congress of Rheumatology (EULAR) 2025, Scipher Medicine, the company behind ...

Functional MRI studies have established that subjective feelings of pain and fatigue have objective correlates in terms of neuronal activity patterns. This study sought to determine whether neural ...

Among patients with rheumatoid arthritis-associated interstitial lung disease, there was no significant difference in the ...

Gender-based differences were identified in the clinical characteristics and time to initiation of the first biologic or targeted synthetic disease-modifying antirheumatic drug (b/ts DMARD) among ...

Polypharmacy in RA patients is linked to increased drug interaction risks, especially with immunosuppressants, necessitating careful management and monitoring. Older age and multiple comorbidities are ...